Supporting innovation from concept to market<\/strong> A CDMO typically offers integrated services across the full product lifecycle. These may include formulation development, analytical testing, process optimisation, scale-up, clinical manufacturing, validation, and commercial production. Working with a CDMO offers important strategic advantages. It reduces the need for major investment in facilities, equipment, and specialised skils, while providing access to proven technical knowledge and manufacturing experience. In the case of LTS, this expertise and know how extends across a wide range of delivery technologies including Transdermal Therapeutic Systems, Oral Thin Films, Microneedle Array Patches, Topical Patch Systems, On Body Delivery Systems and Nasal Drug Delivery. To find out more about our technology platforms\u00a0click here.<\/a>\u00a0<\/strong> Expertise matters<\/strong> A partner for progress<\/strong> Pharmaceutical development, from first principles, feasibility, prototyping and clinical trials through to manufacturing of high volumes is defined by complexity, precision and high standards. As programmes move from concept to commercialisation, many companies choose to partner with a contract manufacturer that is equipped with specialised expertise, dedicated infrastructure and reliability through experience.<\/p>\n Necessarily contract manufacturing in pharma is more than an outsourcing arrangement. It is a strategic collaboration that helps bring products to market efficiently, consistently and in compliance with ever evolving, ever increasingly demanding regulatory expectations. For organisations seeking to scale with confidence, the right partner can make a seismic impact at every stage of the journey.<\/p>\n<\/div><\/div><\/div> At its best, contract manufacturing represents a seamless extension of your own organisation. It allows pharmaceutical companies to focus on innovation, development and market strategy while relying on an experienced partner to manage your manufacturing requirements.<\/p>\n This model is particularly valuable in an industry where quality and continuity of supply are essential to ensure patients continue to benefit from often lifesaving or life enhancing therapies. Only by working with a trusted manufacturing partner, can companies reduce the burden of capital investment while responding with agility to shifting market needs.<\/p>\n<\/div><\/div><\/div> The pharmaceutical sector operates under strict regulatory scrutiny and exceptionally low tolerance for error. Every process must be built to protect product quality, ensure traceability, and support the highest levels of patient safety.<\/p>\n Contract manufacturing helps companies meet these demands while maintaining operational agility. It can shorten time to market, improve production efficiency, and provide access to specialised equipment or expertise that may not be available internally. For many organisations, it also offers a more flexible path to growth without compromising standards.<\/p>\n<\/div><\/div><\/div> The value of contract manufacturing extends well beyond production itself. A strong partner contributes insight during planning, alignment during development and consistency during scale-up and supply.<\/p>\n That value can only be created through early collaboration. When manufacturing considerations are addressed from the outset, it becomes easier to manage specifications, reduce risk and establish a more reliable path forward. Clear communication around timelines, sourcing, and quality expectations also helps prevent delays and supports long-term operational stability.<\/p>\n<\/div><\/div><\/div> Not all manufacturing partnerships are created equal. In pharma, the best outcomes depend on technical capability, regulatory discipline and a shared commitment to quality.<\/p>\n A strong contract manufacturing partner should offer more than capacity. It should bring proven experience, robust systems and the ability to work as an extension of your team. Just as importantly, it should support transparent planning and responsive execution, ensuring that every step is aligned with your programme goals.<\/p>\n When managed with the right partner, it becomes a foundation for sustainable growth. The result is not simply outsourced production, but a relationship built to support quality, continuity and long-term success.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div> Most modern patches consist of (at least) three essential layers:<\/p>\n Most modern patches consist of (at least) three essential layers:<\/p>\n Once applied, the drug moves from the patch into the stratum corneum (the skin’s outermost barrier layer). It then diffuses through the deeper epidermis and dermis until it reaches capillaries, which absorb the drug into the general circulation.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div>
\nBringing a pharmaceutical product to market requires far more than a promising molecule. It demands careful development, robust process design and a manufacturing strategy that can support the entire development process from feasibility, first prototypes, clinical trials through to commercial launch and lifecycle management. A CDMO provides the capabilities needed to move efficiently through these stages while helping partners maintain focus on their core scientific objectives.<\/div><\/div><\/div><\/i><\/i><\/span>What a CDMO offers<\/span><\/a><\/h2><\/div>
\nBy bringing these functions together within one consistent and valued partnership, pharma companies create a more seamless path from early development to market supply. This integrated approach can help reduce complexity, improve coordination, and support greater continuity across each phase of development.<\/p>\n<\/div><\/div><\/div><\/i><\/i><\/span>Why choose a LTS as your CDMO?<\/span><\/a><\/h2><\/div>
\nFor our partners, this model offers flexibility and speed, allowing its teams to adapt to changing development needs, respond to regulatory expectations and scale production with confidence.<\/p>\n
\nIn pharmaceutical development, expertise is essential. Each product presents unique scientific, technical, and regulatory challenges, and success depends on the ability to manage them with precision. A strong CDMO partner does more than provide capacity. It contributes insight, continuity and execution across the entire journey, helping ensure that development and manufacturing are aligned with long-term product goals.<\/p>\n
\nAs the pharmaceutical industry continues to evolve, the role of the CDMO becomes increasingly important. Pharma companies are seeking trusted partners who can combine innovation with operational excellence and support the delivery of high-quality products to patients around the world.
\nFor more information on our CDMO capabilities click here<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/i><\/i><\/span>What is contract manufacturing in pharma?<\/span><\/a><\/h2><\/div>
<\/i><\/i><\/span>A strategic partnership<\/span><\/a><\/h2><\/div>
<\/i><\/i><\/span>Why contract manufacturing matters?<\/span><\/a><\/h2><\/div>
<\/i><\/i><\/span>Where value is created?<\/span><\/a><\/h2><\/div>
<\/i><\/i><\/span>Choosing the right partner<\/span><\/a><\/h2><\/div>
TTS<\/h2><\/div><\/div><\/div>
<\/i><\/i><\/span>What is a Transdermal Therapeutic System (TTS)?<\/span><\/a><\/h2><\/div>
<\/i><\/i><\/span>What are the main components of a TTS?<\/span><\/a><\/h2><\/div>
\n
\n
<\/i><\/i><\/span>How does the medication enter the body?<\/span><\/a><\/h2><\/div>
<\/i><\/i><\/span>What are the primary advantages?<\/span><\/a><\/h2><\/div>
\n